Bayer HealthCare Pharmaceuticals is recalling approximately 104,128 bottles of Bayer Chewable Low Dose Aspirin 81 mg (orange flavored). The recall was initiated because the product failed stability specifications, meaning the medication may not maintain its expected effectiveness or quality through the end of its labeled shelf life. This recall affects 36-count HDPE bottles distributed nationwide. Consumers should consult with a healthcare professional regarding any concerns about the effectiveness of their medication.
The product failed stability testing, which can lead to the medication losing its potency or chemical integrity before the expiration date. While this is considered a low-risk situation, the medication may not provide the full therapeutic benefit intended for the user.
Refund or guidance for affected medication
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.